No Relief: R&D Expenses Must Be Amortized
The $1.7 trillion federal omnibus spending package that was signed by President Biden on Friday, December 23 did not include a provision to reverse the recently enacted requirement that businesses amortize their R&D expenses. This was despite industry pressure for an extension or removal of the requirement to begin amortizing R&D expenditures, which went into […]
No Relief: R&D Expenses Must Be Amortized Read More »